Literature DB >> 21483236

Role of FDG-PET/CT in diagnosis, staging, response to treatment, and prognosis of pancreatic cancer.

Gaia Grassetto, Domenico Rubello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21483236     DOI： 10.1097/COC.0b013e3181d275a0

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN： 0277-3732            Impact factor:   2.339


× No keyword cloud information.
  9 in total

1.  FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.

Authors:  Zhen Wang; Jun-Qiang Chen; Jin-Lu Liu; Xin-Gan Qin; Yuan Huang
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

2.  The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma.

Authors:  Lujaien A Kadhim; Avani S Dholakia; Joseph M Herman; Richard L Wahl; Muhammad A Chaudhry
Journal:  J Radiat Oncol       Date:  2013-10-30

3.  Evaluation of the Metabolic Response to Cyclopamine Therapy in Pancreatic Cancer Xenografts Using a Clinical PET-CT System.

Authors:  Hany Kayed; Patrick Meyer; Yong He; Bettina Kraenzlin; Christian Fink; Norbert Gretz; Stefan O Schoenberg; Maliha Sadick
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

4.  Functional imaging of interstitial brachytherapy in pancreatic carcinoma xenografts using spectral CT: how does iodine concentration correlate with standardized uptake value of (18)FDG-PET-CT?

Authors:  Shudong Hu; Xiaofeng Shi; Yerong Chen; Wei Huang; Qi Song; Xiaozhu Lin; Yu Liu; Kemin Chen; Zhongmin Wang
Journal:  Br J Radiol       Date:  2015-12-07       Impact factor: 3.039

5.  Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer.

Authors:  Jian-Guo Zhao; Ya Hu; Quan Liao; Zhe-Yu Niu; Yu-Pei Zhao
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

6.  Impact of Plasma Glucose Level at the Time of Fluorodeoxyglucose Administration on the Accuracy of FDG-PET/CT in the Diagnosis of Pancreatic Lesions.

Authors:  Alireza Hamidian Jahromi; Mohammad Kazem Fallahzadeh; Amol Takalkar; Jean Sheng; Gazi Zibari; Hosein Shokouh Amiri
Journal:  Int J Endocrinol Metab       Date:  2014-10-01

Review 7.  Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis.

Authors:  Dongyong Zhu; Lisha Wang; Hanfei Zhang; Jie Chen; Yanfang Wang; Sama Byanju; Meiyan Liao
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

8.  Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.

Authors:  Chang Moo Kang; Sung Hwan Lee; Ho Kyoung Hwang; Mijin Yun; Woo Jung Lee
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study.

Authors:  Entesar Dalah; An Tai; Kiyoko Oshima; William A Hall; Beth Erickson; X Allen Li
Journal:  Transl Oncol       Date:  2018-07-17       Impact factor: 4.243
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.